These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8617704)
1. The making of a user friendly MAOI diet. Gardner DM; Shulman KI; Walker SE; Tailor SA J Clin Psychiatry; 1996 Mar; 57(3):99-104. PubMed ID: 8617704 [TBL] [Abstract][Full Text] [Related]
2. Refining the MAOI diet: tyramine content of pizzas and soy products. Shulman KI; Walker SE J Clin Psychiatry; 1999 Mar; 60(3):191-3. PubMed ID: 10192596 [TBL] [Abstract][Full Text] [Related]
4. Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors. Shulman KI; Walker SE; MacKenzie S; Knowles S J Clin Psychopharmacol; 1989 Dec; 9(6):397-402. PubMed ID: 2592589 [TBL] [Abstract][Full Text] [Related]
5. Diet and monoamine oxidase inhibitors: a re-examination. Sullivan EA; Shulman KI Can J Psychiatry; 1984 Dec; 29(8):707-11. PubMed ID: 6394124 [TBL] [Abstract][Full Text] [Related]
6. Clarifying the safety of the MAOI diet and pizza. Feinberg S; Holzer B J Clin Psychiatry; 2000 Feb; 61(2):145-6. PubMed ID: 10732665 [No Abstract] [Full Text] [Related]
7. Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer. Tailor SA; Shulman KI; Walker SE; Moss J; Gardner D J Clin Psychopharmacol; 1994 Feb; 14(1):5-14. PubMed ID: 8151003 [TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up? Sweet RA; Brown EJ; Heimberg RG; Ciafre L; Scanga DM; Cornelius JR; Dube S; Forsyth KM; Holt CS J Clin Psychiatry; 1995 May; 56(5):196-201. PubMed ID: 7737959 [TBL] [Abstract][Full Text] [Related]
9. Dietary tyramine and other pressor amines in MAOI regimens: a review. McCabe BJ J Am Diet Assoc; 1986 Aug; 86(8):1059-64. PubMed ID: 3525654 [TBL] [Abstract][Full Text] [Related]
10. Practical aspects of MAO inhibitor therapy. Davidson J; Zung WW; Walker JI J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):81-4. PubMed ID: 6735999 [TBL] [Abstract][Full Text] [Related]
12. [Monoamine oxidase inhibitors and food precautions. A comparison of utilization in Belgian psychiatric education institutes and current findings in the literature]. Mallet L; Schittecatte M Acta Psychiatr Belg; 1996; 96(2):74-100. PubMed ID: 8693949 [TBL] [Abstract][Full Text] [Related]
16. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice. Cooper AJ Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126 [TBL] [Abstract][Full Text] [Related]
17. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. Rapaport MH J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157 [TBL] [Abstract][Full Text] [Related]
18. Tyramine studies and the safety of MAOI drugs. Simpson GM; White K J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):59-61. PubMed ID: 6735997 [TBL] [Abstract][Full Text] [Related]
19. The monoamine oxidase inhibitor-tyramine interaction. Brown C; Taniguchi G; Yip K J Clin Pharmacol; 1989 Jun; 29(6):529-32. PubMed ID: 2666453 [TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase inhibitors: safety and efficacy issues. Brown CS; Bryant SG Drug Intell Clin Pharm; 1988 Mar; 22(3):232-5. PubMed ID: 3284731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]